Latest News

Are you on an Infusion Treatment?

May 30, 2024 | Advocacy, Treatments

At MSNZ we would like to understand more about patient experiences with infusion treatments. The first line Disease Modifying Treatment (DMT) options we have been successful in advocating for in NZ are considered some of the best in the world. […]


World Health Organisation adds three Disease Modifying Therapies for MS onto Essential Medicine List

July 27, 2023 | Treatments

Image: myriam-zilles-unsplash Today, the World Health Organisation (WHO) added three Disease Modifying Treatments (DMTs) for Multiple Sclerosis (MS) onto its Essential Medicines List for the first time. Addressing the global MS movement, Prof Mai Sharawy, Chair of the Board of […]


Addressing the unmet need

September 14, 2022 | Advocacy, Progressive, Treatments

Currently, only approximately 1900 of the over 4130 New Zealanders diagnosed with MS are able to access funded Disease Modifying Therapies (DMTs). In particular, those with progressive forms of MS, Secondary (SPMS) and Primary Progressive MS (PPMS), have extremely limited […]


Media Release – Kiwis with MS ‘light years’ behind Aussie patients in treatment access and quality of life – study.

September 14, 2021 | Advocacy, Media, Study, Uncategorised

Media Release: 14 September 2021 (For Immediate Release) A new trans-Tasman study has highlighted alarming health inequities between New Zealand patients living with multiple sclerosis (MS) and their Australian counterparts — adding fuel to the ongoing fight for Pharmac to […]


Ethical use of Off-label disease-modifying therapies used in MS

August 3, 2021 | Education, Treatments, Uncategorised

The MS International Federation’s Atlas of MS showed that off-label disease-modifying therapies are used in at least 89 countries. This highlights the need for  transparent evidence-based guidelines to support clinical decision-making, pharmaceutical policies and reimbursement decisions.  Because there has been […]